Correlation of astrocytic S100β expression with dystrophie neurites in amyloid plaques of Alzheimer's disease

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 3, 1996, Pages 273-279

  Mrak, Robert E ^a,b   Sheng, Jin G ^a,b,c   Griffin, W Sue T ^a,b,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; S100 protein; amyloid plaque evolution; amyloid precursor protein

Indexed keywords

AMYLOID; NEURITE PROMOTING FACTOR;

AGED; ALZHEIMER DISEASE; AMYLOID NEUROPATHY; ARTICLE; ASTROCYTE; BRAIN BIOPSY; CELL KINETICS; CELL PROLIFERATION; CLINICAL ARTICLE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE FIBER GROWTH; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS REGULATION;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ASTROCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEURITES;

EID: 0029670066     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199603000-00002     Document Type: Article

References (27)

1. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105
2. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-86
3. Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 1989;48:674-91
4. Griffin WST, Stanley LC, Ling C, et al. Brain interleukin-1 and S100 immunoreactivity elevated in Down's syndrome and Alzheimer's disease. Proc Natl Acad Sci USA 1989;86:7611-15
5. Griffin WST, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW. Microglial interleukin-1α expression in human head injury: Correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci Letts 1994;176:133-36
6. Griffin WST, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer's disease. J Neuropathol Exp Neurol 1995;54:276-81
7. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 1988;8:2485-90
8. Duffy PE, Rapapport M, Graf L. Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology 1980;30:778-82
9. Itagaki S. McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989;24:173-82
10. Mandybur TI, Chuirazzi BA. Astrocytes and the plaques of Alzheimer's disease. Neurology 1990;40:635-39
11. Delacourte A. General and dramatic glial reaction in Alzheimer brains. Neurology 1990;40:33-37
12. Marshak DR, Pesce SA, Stanley LC, Griffin WST. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe. Neu robiol Aging 1991;13:1-7
13. Sheng JG. Mrak RE, Griffin WST. S100β protein expression in Alzheimer's disease: Potential role in the pathogenesis of neuritic plaques. J Neurosci Res 1994;39:398-404
14. Wu JH, Sheng JG, Skinner RA, Stanley LC, Wall T, Griffin WST Interleukin-1-(IL-1) induced expression of Alzheimer disease-related proteins in rat brain. Soc Neurosci Abs 1993;19(Part 2):1037
15. Kligman D, Marshak DR. Purification and characterization of a neunte extension factor from bovine brain. Proc Natl Acad Sci USA 1985;82:7136-39
16. Bhattacharyya A, Oppenheim RW, Prevetta D, Moore BW, Brackenbury R, Ratner N. S100 is present in developing chicken neurons and Schwann cells and promotes neuron survival in vivo. J Neurobiol 1992;23:451-66
17. Van Eldik LJ, Griffin WST. S100β expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochim Biophys Acta 1994;1223:398-403
18. Roberts GW, Lofthouse R, Allsop D, et al. CNS amyloid proteins in neurodegenerative diseases. Neurology 1988;38:1534-40
19. Griffin WST, Stanley LC, Yeralan O, Rovnaghi CR, Marshak DR Methods for the study of cytokines in human neurodegenerative disease. Met Neurosci 1993;17:268-87
20. da Cunha A, Jefferson JJ, Tyor WR, Glass JD, Jannotta FS, Vitkovic L. Gliosis in human brain: Relationship to size but not other properties of astrocytes. Brain Res 1993;600:161-65
21. Sarnat HB. Regional differentiation of the human fetal ependyma: Immunocytochemical markers. J Neuropathol Exp Neurol 1992;51. 58-75
22. Griffin WST Yeralan O, Sheng JG, Boop FA, Mrak RE, Rovnaghi CR, Feoktistova A, Burnett BA, Van Eldik LJ. Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy. J Neurochcm 1995;65:228-33
23. Stanley LC, Mrak RE, Woody RC, et al. Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol 1994;53:231-38
24. Kato K, Suzuki F, Morishita R, Asano T, Sato T. Selective increase in S-100β protein by aging in rat cerebral cortex. J Neurochem 1990;54:1269-74
25. Sheng JG, Mrak RE, Rovnaghi CR, Kozlowska E, Van Eldik LJ, Griffin WST. Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease. Neurobiol Aging (in press)
26. Griffin WST, Stanley LC. Glial activation as a common denominator in neurodegenerative disease: A hypothesis in neuropathology. In: Fedoroff S, Juurlink BHJ, Doucette R, Burkholder G. eds. Biology and pathology of astrocyte-neuron interactions. Altschul Symposium Series. New York: Plenum Press, 1993;2:359-82
27. Mrak RE, Sheng JG, Griffin WST. Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Human Pathol 1995;26:816-23